Retatrutide is a new medication in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By activating these receptors, Retatrutide controls cravings, {promotesenergy expenditure, and ultimately contributes to significant weight loss. While studies ar